O'Brien Stephen Paul has filed 5 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 15000 shares of Tvardi Therapeutics, Inc. ($TVRD) on January 29, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Tvardi Therapeutics, Inc. | $TVRD | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 9,377,079 | 9999.99% | 0.16% |
| Dec. 16, 2025 | Tvardi Therapeutics, Inc. | $TVRD | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 9,377,079 | 9999.99% | 0.04% |
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 7213 | $0.00 | 7,213.0000 | 1,524,116 | 9999.99% | 0.47% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 11399 | $0.00 | 11,399.0000 | 1,524,116 | 9999.99% | 0.75% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | O'Brien Stephen Paul | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 3352 | $0.00 | 3,352.0000 | 1,524,116 | 9999.99% | 0.22% |